Comparable stake leader
GILEAD SCIENCES, INC.
SEC ownership of Lakefront Biotherapeutics NV
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001421876.
Disclosed value leader
GILEAD SCIENCES, INC.
Comparable rows
50/50
Latest evidence
15 Jun 2026
- Public ticker
- LKFT on Nasdaq, GLPGF on OTC
- Parsed ownership sources
-
13D/G and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
GILEAD SCIENCES, INC.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
GILEAD SCIENCES, INC.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
15 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001421876
- Issuer location
- 2800 Mechelen
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Lakefront Biotherapeutics NV (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GILEAD SCIENCES, INC.
Disclosed value leader
GILEAD SCIENCES, INC.
Comparable rows
50/50
Latest evidence
15 Jun 2026
13D/G
13F
Lead comparable stake: 30%
13D/G row: GILEAD SCIENCES, INC.
Showing 1-8 of 50 holder rows.
Quick read
GILEAD SCIENCES, INC. leads the comparable SEC ownership view at 30%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GILEAD SCIENCES, INC.'s linked filing trail.
Comparable ownership
Top 5
GILEAD SCIENCES, INC.
30%
EcoR1 Capital, LLC
13%
TANG CAPITAL MANAGEMENT LLC
8.4%
Madison Avenue Partners, LP
5.5%
Prosight Management, LP
2.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. |
13D/G
13F
Company
|
30%
|
$555,786,955
20,981,010 shares
|
$0 | 07 Jan 2025 |
| EcoR1 Capital, LLC |
13D/G
13F
Company
|
13%
|
$243,919,471
8,714,522 shares
|
+$25,507,847 | 24 Jul 2025 |
| TANG CAPITAL MANAGEMENT LLC |
13D/G
13F
Company
|
8.4%
|
$192,587,107
5,559,674 shares
|
+$22,486,521 | 27 Oct 2025 |
| Madison Avenue Partners, LP |
13D/G
13F
Madison Avenue International LP · Company
|
5.5%
|
$95,961,062
3,606,203 shares
|
$0 | 15 Jun 2026 |
| Prosight Management, LP |
13F
Company
|
2.4%
|
$46,500,000
1,550,000 shares
|
— | 31 Mar 2026 |
| AMERIPRISE FINANCIAL INC |
13F
Company
|
2.2%
|
$42,740,220
1,424,674 shares
|
— | 31 Mar 2026 |
| DME Capital Management, LP |
13F
Company
|
0.74%
|
$14,482,380
482,746 shares
|
— | 31 Mar 2026 |
| SEGALL BRYANT & HAMILL, LLC |
13F
Company
|
0.65%
|
$12,792,360
426,412 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 04 Jul 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Recent insider transactions for Lakefront Biotherapeutics NV
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.